Wallen Tyler, Carter Timothy, Habertheuer Andreas, Badhwar Vinay, Jacobs Jeffrey P, Yerokun Babatunde, Wallace Amelia, Milewski Karianna, Szeto Wilson Y, Bavaria Joseph E, Vallabhajosyula Prashanth
Division of Cardiovascular Surgery, The University of Florida, Gainesville, Florida.
Division of Cardiovascular Surgery, The University of Pennsylvania Health System, Philadelphia, Pennsylvania.
Aorta (Stamford). 2021 Feb;9(1):21-29. doi: 10.1055/s-0041-1724003. Epub 2021 Oct 4.
Hybrid arch procedures (arch vessel debranching with thoracic endovascular aneurysm repair [TEVAR] coverage of arch pathology) have been presented as an alternative to total arch replacement (TAR). But multicenter-based analyses of these two procedures are needed to benchmark the field and establish areas of improvement.
The Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database from July 2014 to December 2015 was queried for elective TAR and hybrid arch procedures. Demographics and operative characteristics were compared and stepwise variable selection was used to create a risk-set used for adjustment of all multivariable models.
A total of 1,011 patients met inclusion criteria, 884 underwent TAR, and 127 had hybrid arch procedures. TAR patients were younger (mean age: 62.7 ± 13.3 vs. 66.7 ± 11.9 years; = 0.001) and had less peripheral vascular disease (34.0 vs. 49.6%; < 0.001) and preoperative dialysis (1.7 vs. 4.7%; = 0.026), but similar history of stroke ( = 0.91)/cerebrovascular disease ( = 0.52). TAR patients had more concomitant procedures (60 vs. 34.6%; < 0.0001). TAR patients had lower mortality (6.7 vs. 12.6%; = 0.02), stroke (6.9 vs. 15%; = 0.002), paralysis (1.8 vs. 7.1%; = 0.002), renal failure (4.6 vs. 8.7%; = 0.045), and STS morbidity (34.2 vs. 42.5%; = 0.067). Composite mortality, stroke, and paralysis were significantly lower with TAR (11.5 vs. 25.2%; = 0.0001). After risk adjustment, analysis showed hybrid arch procedures imparted an increased odds of mortality (odds ratio [OR] = 1.91, = 0.046), stroke (OR = 2.3, = 0.005), and composite endpoint of stroke or mortality (OR = 2.31, = 0.0002).
TAR remains the gold standard for elective aortic arch pathologies. Despite risk adjustment, hybrid arch procedures were associated with increased risk of mortality and stroke, advocating for careful adoption of these strategies.
杂交主动脉弓手术(主动脉弓血管去分支并采用胸主动脉腔内修复术[TEVAR]覆盖主动脉弓病变)已被视为全主动脉弓置换术(TAR)的一种替代方案。但需要对这两种手术进行多中心分析,以便为该领域设定基准并确定改进方向。
查询胸外科医师协会(STS)2014年7月至2015年12月的成人心脏手术数据库,以获取择期TAR和杂交主动脉弓手术的相关信息。比较人口统计学和手术特征,并采用逐步变量选择法创建一个风险集,用于调整所有多变量模型。
共有1011例患者符合纳入标准,884例行TAR,127例行杂交主动脉弓手术。TAR患者更年轻(平均年龄:62.7±13.3岁对66.7±11.9岁;P = 0.001),外周血管疾病更少(34.0%对49.6%;P < 0.001),术前透析更少(1.7%对4.7%;P = 0.026),但卒中(P = 0.91)/脑血管疾病(P = 0.52)病史相似。TAR患者同期进行的其他手术更多(60%对34.6%;P < 0.0001)。TAR患者的死亡率(6.7%对12.6%;P = 0.02)、卒中(6.9%对15%;P = 0.002)、瘫痪(1.8%对7.1%;P = 0.002)、肾衰竭(4.6%对8.7%;P = 0.045)和STS并发症(34.2%对42.5%;P = 0.067)更低。TAR的综合死亡率、卒中和瘫痪显著更低(11.5%对25.2%;P = 0.0001)。风险调整后分析显示,杂交主动脉弓手术使死亡几率增加(优势比[OR]=1.91,P = 0.046)、卒中几率增加(OR = 2.3,P = 0.005)以及卒中和死亡的复合终点几率增加(OR = 2.31,P = 0.0002)。
TAR仍然是择期主动脉弓病变的金标准。尽管进行了风险调整,但杂交主动脉弓手术与死亡和卒中风险增加相关,因此提倡谨慎采用这些策略。